1. Valeant's Largest Shareholder: 'It hurts'

    Valeant's Largest Shareholder: 'It hurts'

    Sequoia Fund, the large mutual fund managed by Robert Goldfarb and David Poppe, has posted a letter on the homepage of its website defending its massive investment in Valeant Pharmaceuticals.  Shares of the Canadian drug company have collapsed since last Wednesday. That is when Citron Research, the short-selling firm run by Andrew Left, published a report asking whether Valeant was operating an Enron-like fraud.  Valeant's share price has declined by more than 40% since the report came out...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      Board Recruitment Publication, BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned

  3. Authors